TA
CVS icon

Tamarack Advisers’s CVS Health CVS Stock Holding History

Tamarack Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$4.77M – 41
2022
Q3 		$4.77M Buy
+50,000
New +$4.95M 2.8% 17
2022
Q2 		– Sell
-50,000
Closed -$5.06M – 45
2022
Q1 		$5.06M Buy
50,000
+10,000
+25% +$1.05M 2.39% 15
2021
Q4 		$4.13M Buy
+40,000
New +$3.7M 1.7% 22
2021
Q3 		– Sell
-100,000
Closed -$8.34M – 53
2021
Q2 		$8.34M Sell
100,000
-125,000
-56% -$10.2M 2.36% 16
2021
Q1 		$16.9M Buy
+225,000
New +$16.4M 3.47% 10
2017
Q4 		– Sell
-75,000
Closed -$6.1M – 34
2017
Q3 		$6.1M Buy
+75,000
New +$5.93M 3.73% 13

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tamarack Advisers's CVS Position: Q4 2022 in Review

Tamarack Advisers sold out of CVS Health (CVS) in Q4 2022, closing a stake of 50,000 shares — an estimated $4.77M sold.

Tamarack Advisers first reported a position in CVS in Q3 2017 and held it in 6 quarters. The position peaked at $16.9M in Q1 2021. 2,409 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Tamarack Advisers reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Tamarack Advisers sold 50,000 CVS Health shares in Q4 2022, an estimated $4.77M.
  • Tamarack Advisers first reported a position in CVS Health in Q3 2017 and held it in 6 quarters.
  • Tamarack Advisers's CVS Health position peaked at $16.9M in Q1 2021.
  • 2,409 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Tamarack Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.